The Fly

HCA Healthcare price target raised to $285 from $240 at Loop Capital

Loop Capital analyst Joseph France raised the firm’s price target on HCA Healthcare to $285 from $240 and keeps a Buy rating on the shares. The company’s Q4 results were "solid" and its 2024 growth should return to more normal long-term trends after enduring headwinds in 2023, the analyst tells investors in a research note. The firm also states that it was impressed with the company’s progress on staffing, where a quick fix could accelerate HCA’s recovery from the pandemic.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on HCA:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More